• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淋巴结阴性乳腺癌的经典预后因素:丹麦乳腺癌协作组(DBCG)的经验

Classical prognostic factors in node-negative breast cancer: the DBCG experience.

作者信息

Mouridsen H T, Andersen J, Andersen K W, Axelsson C, Blichert-Toft M, Dombernowsky P, Hansen M, Krag C, Overgård M, Rasmussen B B

机构信息

Department of Oncology, Rigshospitalet, Copenhagen, Denmark.

出版信息

J Natl Cancer Inst Monogr. 1992(11):163-6.

PMID:1627423
Abstract

Classical prognostic factors were analyzed in patients with low-risk primary breast cancer, defined as absence of tumor-positive axillary lymph nodes, tumor size less than or equal to 5 cm in diameter, and no invasion into skin or deep fascia. The primary surgical treatment was total mastectomy and lower axillary dissection. None of the patients received adjuvant therapy. Between 1977 and 1990, 7315 patients entered the study, and at the time of this analysis (January 1, 1990), the median follow-up time is 5 years. In univariate analyses, the following variables were significantly related to recurrence-free survival: age in premenopausal patients; tumor size; number of negative nodes removed; histological grade; and in premenopausal patients, estrogen receptor and progesterone (PgR) status. In multivariate analyses, age in premenopausal patients was the most important factor, followed by tumor size and histological grade, whereas PgR status in premenopausal patients was just of borderline significance. These variables should be included in multivariate analyses testing the value of more recently introduced prognostic factors.

摘要

对低风险原发性乳腺癌患者的经典预后因素进行了分析,低风险原发性乳腺癌定义为无肿瘤阳性腋窝淋巴结、肿瘤直径小于或等于5厘米且未侵犯皮肤或深筋膜。主要手术治疗方式为全乳切除术和低位腋窝清扫术。所有患者均未接受辅助治疗。1977年至1990年期间,7315例患者进入该研究,在本次分析时(1990年1月1日),中位随访时间为5年。在单因素分析中,以下变量与无复发生存显著相关:绝经前患者的年龄;肿瘤大小;切除的阴性淋巴结数量;组织学分级;以及绝经前患者的雌激素受体和孕激素(PgR)状态。在多因素分析中,绝经前患者的年龄是最重要的因素,其次是肿瘤大小和组织学分级,而绝经前患者的PgR状态仅具有临界显著性。在检验最近引入的预后因素价值的多因素分析中应纳入这些变量。

相似文献

1
Classical prognostic factors in node-negative breast cancer: the DBCG experience.淋巴结阴性乳腺癌的经典预后因素:丹麦乳腺癌协作组(DBCG)的经验
J Natl Cancer Inst Monogr. 1992(11):163-6.
2
LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.LEA-135表达:其与淋巴结阳性原发性浸润性乳腺癌患者较低的复发风险及总生存期延长的相关性。
Anticancer Res. 2004 Jul-Aug;24(4):2391-400.
3
Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.腋窝淋巴结转移阳性率可预测非转移性乳腺癌患者的生存率。
Acta Oncol. 2008;47(2):232-8. doi: 10.1080/02841860701678761.
4
Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.保乳手术联合放疗治疗早期乳腺癌的治疗结果及预后因素
Jpn J Clin Oncol. 2005 Mar;35(3):126-33. doi: 10.1093/jjco/hyi039.
5
Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.在接受多柔比星和环磷酰胺序贯紫杉醇辅助化疗的III期乳腺癌患者中,bcl-2表达的预后意义
BMC Cancer. 2007 Apr 12;7:63. doi: 10.1186/1471-2407-7-63.
6
Identifying good prognosis group of breast cancer patients with 1-3 positive axillary nodes for adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapy.确定腋窝淋巴结1 - 3个阳性的乳腺癌患者中可从辅助性环磷酰胺、甲氨蝶呤和5 - 氟尿嘧啶(CMF)化疗中获益的预后良好组。
Jpn J Clin Oncol. 2005 Sep;35(9):514-9. doi: 10.1093/jjco/hyi143.
7
Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.bcl-2蛋白的表达可预测可手术的淋巴结阳性乳腺癌辅助治疗的疗效。
Clin Cancer Res. 1995 Feb;1(2):189-98.
8
Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.选择具有T1-T2肿瘤且腋窝淋巴结有1至3个阳性、保乳术后局部区域复发风险高的乳腺癌患者进行辅助放疗。
Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1337-47. doi: 10.1016/j.ijrobp.2004.08.009.
9
[Does primary tumor affect the prognosis in postmastectomy locoregional recurrence in breast carcinoma?].[原发性肿瘤对乳腺癌乳房切除术后局部区域复发的预后有影响吗?]
Strahlenther Onkol. 1995 Jan;171(1):18-28.
10
Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer.骨髓中孤立肿瘤细胞的检测是乳腺癌的一个独立预后因素。
J Clin Oncol. 2003 Sep 15;21(18):3469-78. doi: 10.1200/JCO.2003.02.009.

引用本文的文献

1
Integration of risk factors to allow patient selection for adjuvant systemic therapy in lymph node-negative breast cancer patients.
World J Surg. 1994 Jan-Feb;18(1):39-44. doi: 10.1007/BF00348190.
2
The Nottingham Prognostic Index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG).将诺丁汉预后指数应用于丹麦乳腺癌协作组(DBCG)研究中的9149例患者。
Breast Cancer Res Treat. 1994;32(3):281-90. doi: 10.1007/BF00666005.